Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology

被引:4
|
作者
Qiang, Rui [1 ]
Zhang, Ya [1 ,2 ]
Wang, Yanhong [3 ,4 ]
机构
[1] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing 100053, Peoples R China
[2] Shaanxi Univ Chinese Med, Xianyang 712046, Peoples R China
[3] Tongji Univ, Tongji Hosp, Sch Med, Dept Orthoped, Shanghai 200065, Peoples R China
[4] Minist Educ, Key Lab Spine & Spinal Cord Injury Repair & Regene, Shanghai 200065, Peoples R China
基金
中国国家自然科学基金;
关键词
PROTEIN; 90; INHIBITOR; LIVER FIBROSIS; BETA-SITOSTEROL; STELLATE CELLS; QUERCETIN; PREDICTION; INJURY; INFLAMMATION; PROGRESSION; DOCKING;
D O I
10.1155/2022/8925637
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Purpose. To explore the material basis and pharmacological mechanism of Xiaochaihu Decoction (XCHD), the classic Traditional Chinese Medicine (TCM) formula in inhibiting hepatic fibrosis (HF). Methods. The main components in XCHD were screened from the TCMSP database, ETCM database, and literature, and their potential targets were detected and predicted using the Swiss Target Prediction platform. The HF-related targets were retrieved and screened through GeneCard database and OMIM database, combined with GEO gene chips. The XCHD targets and HF targets were mapped to search common targets. The protein-protein interaction (PPI) network was acquired via the STRING11.0 database and analyzed visually using Cytoscape 3.8.0 software. The potential mechanisms of the common targets identified through GO and KEGG pathway enrichment analysis were analyzed by using Metascape database. The results were visualized through OmicShare Tools. The "XCHD compound-HF target" network was visually constructed by Cytoscape 3.8.0 software. AutoDockVina1.1.2 and PyMoL software were used to verify the molecular docking of XCHD main active compounds and HF key targets. Results. A total of 164 potential active compounds from XCHD were screened to act on 95 HF-related targets. Bioinformatics analysis revealed that quercetin, beta-sitosterol, and kaempferol may be candidate agents, which acted on multiple targets like PTGS2, HSP90AA1, and PTGS1 and regulate multiple key biological pathways like IL-17 signaling pathway, TNF signaling pathway and PI3K-Akt signaling pathway to relieve HF. Moreover, molecular docking suggested that quercetin and PTGS2 could statically bind and interact with each other through amino acid residues val-349, LEU-352, PHE-381, etc. Conclusion. This work provides a systems perspective to study the relationship between Chinese medicines and diseases. The therapeutic efficacy of XCHD on HF was the sum of multitarget and multi-approach effects from the bioactive ingredients. This study could be one of the cornerstones for further research.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Uncovering the Pharmacology of Xiaochaihu Decoction in the Treatment of Acute Pancreatitis Based on the Network Pharmacology
    Zhan, Lianghui
    Pu, Jinbao
    Hu, Yijuan
    Xu, Pan
    Liang, Weiqing
    Ji, Chunlian
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [2] Systems pharmacology dissection of pharmacological mechanisms of Xiaochaihu decoction against human coronavirus
    Lvjie Xu
    Chuipu Cai
    Jiansong Fang
    Qihui Wu
    Jun Zhao
    Zhe Wang
    Pengfei Guo
    Lishu Zheng
    Ailin Liu
    BMC Complementary Medicine and Therapies, 23
  • [3] Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease
    Qichao Hu
    Shizhang Wei
    Jianxia Wen
    Wenwen Zhang
    Yinxiao Jiang
    Caiyan Qu
    Junbao Xiang
    Yanling Zhao
    Xi Peng
    Xiao Ma
    BioData Mining, 13
  • [4] Systems pharmacology dissection of pharmacological mechanisms of Xiaochaihu decoction against human coronavirus
    Xu, Lvjie
    Cai, Chuipu
    Fang, Jiansong
    Wu, Qihui
    Zhao, Jun
    Wang, Zhe
    Guo, Pengfei
    Zheng, Lishu
    Liu, Ailin
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [5] Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease
    Hu, Qichao
    Wei, Shizhang
    Wen, Jianxia
    Zhang, Wenwen
    Jiang, Yinxiao
    Qu, Caiyan
    Xiang, Junbao
    Zhao, Yanling
    Peng, Xi
    Ma, Xiao
    BIODATA MINING, 2020, 13 (01)
  • [6] Role and molecular mechanisms of HuangQiSiJunZi decoction for treating triple-negative breast cancer as explored via network pharmacology and bioinformatics analyses
    Wang, Decai
    Xie, Dongqing
    Meng, Shuai
    Mi, Jiwei
    Wang, Haiming
    Li, Lingsheng
    Zhang, Yin
    Cui, Yixin
    BMC CANCER, 2024, 24 (01)
  • [7] Integration of network pharmacology and serum medicinal chemistry to investigate the pharmacological mechanisms of QiZhuYangGan Decoction in the treatment of hepatic fibrosis
    Deng, Jing-Wei
    Yuan, Su
    Shi, Li-Peng
    Chen, Xin
    Liu, Jun
    Chen, Zhi-Wei
    Tan, Kai-Yue
    Yang, Qian
    Cao, Wen-Fu
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 323
  • [8] Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats
    Gao, Siting
    Wang, Tongzhuang
    Huang, XueKuan
    Jin, Yaqian
    Xu, Yu
    Xi, Yumeng
    Zhang, Jun
    Luo, Yan
    Xu, Hongling
    Guo, Hongli
    Ke, Dazhi
    Wang, Jianwei
    CHINESE MEDICINE, 2020, 15 (01)
  • [9] Exploring the protective effect of Modified Xiaochaihu Decoction against hepatic steatosis and inflammation by network pharmacology and validation in ageing rats
    Siting Gao
    Tongzhuang Wang
    XueKuan Huang
    Yaqian Jin
    Yu Xu
    Yumeng Xi
    Jun Zhang
    Yan Luo
    Hongling Xu
    Hongli Guo
    Dazhi Ke
    Jianwei Wang
    Chinese Medicine, 15
  • [10] Mechanisms of Er Chen Tang on Treating Asthma Explored by Network Pharmacology and Experimental Verification
    Ren, Yuzhe
    Zhang, Haijing
    Yu, Zhou
    Yang, Xiangzheng
    Jiang, Deyou
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (02) : 227 - 237